Lucid Diagnostics Statistics Share Statistics Lucid Diagnostics has 108.19M
shares outstanding. The number of shares has increased by 100.4%
in one year.
Shares Outstanding 108.19M Shares Change (YoY) 100.4% Shares Change (QoQ) 24.57% Owned by Institutions (%) 13.02% Shares Floating 40.34M Failed to Deliver (FTD) Shares 9,517 FTD / Avg. Volume 0.79%
Short Selling Information The latest short interest is 4.79M, so 4.71% of the outstanding
shares have been sold short.
Short Interest 4.79M Short % of Shares Out 4.71% Short % of Float 7.37% Short Ratio (days to cover) 3.97
Valuation Ratios The PE ratio is -0.91 and the forward
PE ratio is -3.03.
Lucid Diagnostics's PEG ratio is
0.05.
PE Ratio -0.91 Forward PE -3.03 PS Ratio 9.52 Forward PS 5.7 PB Ratio 0.01 P/FCF Ratio -0.92 PEG Ratio 0.05
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Lucid Diagnostics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1069.04,
with a Debt / Equity ratio of 0.
Current Ratio 1069.04 Quick Ratio 1069.02 Debt / Equity 0 Debt / EBITDA -0.48 Debt / FCF -0.47 Interest Coverage -1771.23
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $60.36K Profits Per Employee $-632.35K Employee Count 72 Asset Turnover 0.14 Inventory Turnover 20.82
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 19.05% in the
last 52 weeks. The beta is 1.21, so Lucid Diagnostics's
price volatility has been higher than the market average.
Beta 1.21 52-Week Price Change 19.05% 50-Day Moving Average 1.16 200-Day Moving Average 1.14 Relative Strength Index (RSI) 37.53 Average Volume (20 Days) 1,199,008
Income Statement In the last 12 months, Lucid Diagnostics had revenue of 4.35M
and earned -45.53M
in profits. Earnings per share was -1.05.
Revenue 4.35M Gross Profit -3.92M Operating Income -46.05M Net Income -45.53M EBITDA -44.34M EBIT -45.5M Earnings Per Share (EPS) -1.05
Full Income Statement Balance Sheet The company has 22.36M in cash and 21.25M in
debt, giving a net cash position of 1.1M.
Cash & Cash Equivalents 22.36M Total Debt 21.25M Net Cash 1.1M Retained Earnings -203.77B Total Assets 32.8M Working Capital -9.03M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -44.14M
and capital expenditures -646K, giving a free cash flow of -44.79M.
Operating Cash Flow -44.14M Capital Expenditures -646K Free Cash Flow -44.79M FCF Per Share -0.89
Full Cash Flow Statement Margins Gross margin is -90.2%, with operating and profit margins of -1059.64% and -1047.61%.
Gross Margin -90.2% Operating Margin -1059.64% Pretax Margin -1047.61% Profit Margin -1047.61% EBITDA Margin -1020.16% EBIT Margin -1059.64% FCF Margin -1030.51%
